Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) EBT Margin: 2019-2023

Historic EBT Margin for ADC Therapeutics (ADCT) over the last 4 years, with Sep 2023 value amounting to -313.27%.

  • ADC Therapeutics' EBT Margin fell 24603.00% to -313.27% in Q3 2023 from the same period last year, while for Sep 2023 it was -298.67%, marking a year-over-year decrease of 20267.00%. This contributed to the annual value of -73.68% for FY2022, which is 66785.00% up from last year.
  • ADC Therapeutics' EBT Margin amounted to -313.27% in Q3 2023, which was down 14.63% from -273.30% recorded in Q2 2023.
  • Over the past 5 years, ADC Therapeutics' EBT Margin peaked at 990.94% during Q1 2021, and registered a low of -65,349.91% during Q1 2020.
  • Moreover, its 3-year median value for EBT Margin was -313.27% (2023), whereas its average is -292.75%.
  • Its EBT Margin has fluctuated over the past 5 years, first tumbled by 6,294,427bps in 2020, then soared by 6,634,085bps in 2021.
  • Quarterly analysis of 5 years shows ADC Therapeutics' EBT Margin stood at 0.00% in 2019, then tumbled by 6,294,427bps to -62,944.27% in 2020, then spiked by 6,240,115bps to -331.29% in 2021, then surged by 30,236bps to -28.93% in 2022, then tumbled by 24,603bps to -313.27% in 2023.
  • Its EBT Margin was -313.27% in Q3 2023, compared to -273.30% in Q2 2023 and -314.28% in Q1 2023.